MUSTANG BIO, INC. Revenue from Related Parties
MUSTANG BIO, INC. (MBIO) reported Revenue from Related Parties of $0 for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2019-11-12
- MUSTANG BIO, INC. revenue from related parties for the quarter ending 2019-09-30 was $0.00.
- MUSTANG BIO, INC. revenue from related parties for the quarter ending 2019-06-30 was $0.00.
- MUSTANG BIO, INC. revenue from related parties for the quarter ending 2018-09-30 was $0.00.
- MUSTANG BIO, INC. revenue from related parties for the quarter ending 2018-06-30 was $0.00.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 6 month | Revenue from Related Parties 9 month |
|---|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $50.00K 10-Q · filed 2019-11-12 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | $50.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $50.00K 10-Q · filed 2018-05-14 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |